海森药业前三季度净利8820.96万元，同比增长1.45%

Core Insights - The company reported a revenue of 359 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 12.13% [1] - The net profit attributable to shareholders for the same period was approximately 88.21 million yuan, showing a year-on-year increase of 1.45% [1] - In the third quarter, the company achieved a revenue of 117 million yuan, which is a year-on-year increase of 6.74% [1] - The net profit for the third quarter was approximately 27.42 million yuan, indicating a year-on-year decline of 5.17% [1]